Categories
Change Password!
Reset Password!
Supplementing
migraine patients with vitamin D3 helps in reducing migraine frequency and
number of migraine days.
As per a recent randomized, double-blinded, placebo-controlled parallel analysis led by P. Gazerani and colleagues, the Vitamin-D3 supplementation found to reduce migraine attacks in the migraine patients. Vitamin D shows a substantial role in managing various kinds of pain conditions. It is evident from previous studies that the migraineurs exhibit low levels of vitamin D, and this study examined whether vitamin D supplementation would be advantageous in migraine management or not.
The treatment group showed a more significant reduction in migraine days from 6.14 ± 3.60 to 3.28 ± 3.24 than placebo (5.72 ± 4.52 to 4.93 ± 3.24). The treatment group also exhibited a low frequency of migraine than the placebo group at 24th week. No significant difference was noticed in pressure pain thresholds, temporal summation, migraine severity and 1,25(OH)2D levels. The D3-Vitamin group exhibited considerably higher levels of 25(OH)D as compared to the placebo group. No side-effects were recorded during the whole investigation.
These findings
explain the remarkable role of vitamin D in migraine management, but more
extensive studies are needed to validate vitamin D3 as a prophylactic
alternative for migraine.
Current Medical Research and Opinion
A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D3supplementation in adult patients with migraine.
P. Gazerani et al.
Comments (0)